ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,585Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 682

$1.49M Total Retail Price of All Prescriptions

Rank: 33 out of 682

618 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 618 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

29% of this provider’s 618 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

4% of this provider’s 19,239 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,318 836 S3 1 1
LEVOTHYROXINE SODIUM 875 713 2 3
GABAPENTIN 806 328 3 9
OMEPRAZOLE 674 509 4 5
SIMVASTATIN 669 479 5 4
FUROSEMIDE 668 537 6 7
AMLODIPINE BESYLATE 612 497 7 6
METOPROLOL TARTRATE 526 376 8 10
LISINOPRIL 513 356 9 2
NEXIUM 405 271 10 19
METOPROLOL SUCCINATE 404 278 11 16
WARFARIN SODIUM 403 310 12 13
PANTOPRAZOLE SODIUM 385 284 13 29
CLOPIDOGREL 378 278 14 25
AZITHROMYCIN 349 221 15 39
BISOPROLOL-HYDROCHLOROTHIAZIDE 348 225 16 147
ENDOCET 319 78 S2 17 88
GLYBURIDE 317 236 R 18 72
ZOLPIDEM TARTRATE 302 215 19 21
CITALOPRAM HBR 296 201 20 17
ATORVASTATIN CALCIUM 294 252 21 11
SERTRALINE HCL 289 216 22 24
PLAVIX 284 229 23 35
LIDODERM 253 243 24 134
ISOSORBIDE MONONITRATE ER 251 167 25 31
CRESTOR 237 170 26 22
METFORMIN HCL 235 158 27 8
RANITIDINE HCL 224 141 28 28
TRAMADOL HCL 221 191 29 26
CARVEDILOL 213 164 30 23
MELOXICAM 196 123 31 27
DONEPEZIL HCL 193 182 32 30
TAMSULOSIN HCL 192 152 33 33
POTASSIUM CHLORIDE 191 164 34 14
ATENOLOL 189 142 35 18
SYNTHROID 169 128 36 59
HYDROCHLOROTHIAZIDE 165 128 37 12
DIGOXIN 164 142 38 46
RISPERIDONE 161 160 39 82
FLUOXETINE HCL 159 114 40 60
EXELON 155 152 41 104
DIOVAN 146 100 42 42
CLONIDINE HCL 145 114 43 48
POLYETHYLENE GLYCOL 3350 141 124 44 44
HYDRALAZINE HCL 141 131 44 74
CIPROFLOXACIN HCL 140 107 46 58
PROMETHAZINE HCL 138 71 R 47 54
ALPRAZOLAM 136 88 48 90
CHLORZOXAZONE 135 82 R 49 317
IBUPROFEN 133 37 50 79
LYRICA 130 76 51 78
AMOX TR-POTASSIUM CLAVULANATE 127 72 52 110
MECLIZINE HCL 119 85 53 124
OXYCODONE HCL 118 43 S2 54 93
TIZANIDINE HCL 115 39 55 83
NYSTATIN 114 98 56 95
ESCITALOPRAM OXALATE 113 54 57 73
LOSARTAN POTASSIUM 112 75 58 20
AMLODIPINE BESYLATE-BENAZEPRIL 112 81 58 77
DICYCLOMINE HCL 111 84 60 214
METOCLOPRAMIDE HCL 111 52 60 111
FLUCONAZOLE 107 62 62 154
LACTULOSE 105 88 63 100
AMITRIPTYLINE HCL 103 48 R 64 50
TRAZODONE HCL 101 66 65 38
MEGESTROL ACETATE 100 84 R 66 165
OXYCONTIN 100 20 S2 66 178
CYCLOBENZAPRINE HCL 100 21 R 66 65
NAMENDA 95 95 69 41
PROAIR HFA 95 58 69 45
LOVAZA 95 85 69 106
CYMBALTA 94 24 72 51
ALENDRONATE SODIUM 94 71 72 37
AMOXICILLIN 93 57 74 113
FEXOFENADINE HCL 93 72 74 280
PREDNISONE 92 73 76 40
DILTIAZEM 24HR CD 92 73 76 123
DOXYCYCLINE HYCLATE 91 54 78 137
ALLOPURINOL 91 68 78 32
SPIRONOLACTONE 90 60 80 64
NOVOLOG 90 55 80 129
LIPITOR 89 72 82 92
MIRTAZAPINE 86 68 83 52
JANUVIA 85 50 84 62
TRIAMTERENE-HCTZ 84 57 85 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 62 86 34
LANSOPRAZOLE 79 34 87 85
PAROXETINE HCL 76 64 88 53
ONDANSETRON HCL 76 52 88 195
NITROSTAT 75 52 90 161
SULFAMETHOXAZOLE-TRIMETHOPRIM 74 59 91 103
OXYCODONE HCL-ACETAMINOPHEN 73 42 S2 92 98
FENTANYL 72 41 S2 93 86
VITAMIN D2 72 60 93 206
LANTUS 72 47 93 55
JANUMET 71 31 96 200
ABILIFY 71 37 96 179
BUMETANIDE 70 46 98 115
LOSARTAN-HYDROCHLOROTHIAZIDE 69 50 99 56
FLUOCINONIDE 68 44 100 421
CELEBREX 68 60 100 80
KLOR-CON M20 66 43 102 67
ACTOS 66 53 102 151
LEVETIRACETAM 66 57 102 125
PREMARIN 66 61 R 102 132
TRIAMCINOLONE ACETONIDE 65 41 106 149
LEVEMIR 65 44 106 185
ENALAPRIL MALEATE 65 47 106 91
INSULIN SYRINGE 64 39 109 75
OLANZAPINE 63 44 110 168
CARISOPRODOL 60 0 R 111 146
GLYBURIDE-METFORMIN HCL 60 49 R 111 177
FENOFIBRATE 59 31 113 76
DILTIAZEM ER 58 20 114 136
CILOSTAZOL 58 42 114 183
NAPROXEN 57 36 116 97
AVODART 57 34 116 211
CARBIDOPA-LEVODOPA 54 45 118 121
SPIRIVA 53 39 119 49
MUPIROCIN 53 51 119 166
PEN NEEDLE 52 18 121 159
SOTALOL 52 32 121 218
BUPROPION XL 52 30 121 207
SINGULAIR 52 38 121 63
ZIPRASIDONE HCL 51 51 125 316
HYDROXYZINE HCL 51 22 R 125 187
VENTOLIN HFA 50 30 127 101
COMBIVENT 50 37 127 105
THEOPHYLLINE ANHYDROUS 50 48 127 153
LANTUS SOLOSTAR 50 32 127 114
SULINDAC 50 37 127 264
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.